4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bionano Genomics, Inc. (BNGO) operates in the Medical Instruments & Supplies industry and is headquartered in San Diego, United States with about 95 employees. Its market capitalization is roughly $13 million. In the fiscal year ended 2025-12-31, BNGO reported $28M in revenue and ($26M) in net income.
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia.
Interactive charts & full statements → Open the BNGO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $28M | $31M | $36M | $28M | — |
| Gross Profit | $13M | $0M | $10M | $6M | — |
| Operating Income (EBIT) | ($33M) | ($76M) | ($137M) | ($132M) | — |
| Net Income | ($26M) | ($112M) | ($232M) | ($133M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $7M | $8M | $7M | $7M | $6M | — |
| Gross Profit | $3M | $3M | $3M | $4M | $3M | — |
| Operating Income (EBIT) | ($8M) | ($8M) | ($8M) | ($8M) | ($8M) | — |
| Net Income | ($8M) | ($8M) | ($8M) | ($7M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $74M | $77M | $214M | $308M | — |
| Total Liabilities | $29M | $41M | $118M | $58M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BNGO viewer.
About TickerBase · Data methodology & sources